CJC-1295 NO DAC+IPA
Also known as: CJC-1295 / Ipamorelin · Mod GRF (1-29) + Ipamorelin
A combination of CJC-1295 (no-DAC) and Ipamorelin that pairs a short-acting GHRH analog with a GH secretagogue, discussed as a way to support the body’s own growth-hormone release.
Class
GHRH analog + GH secretagogue blend
Default unit
mg
Common route
Subcutaneous
Typical half-life
~30 min (CJC no-DAC) / ~2 hr (Ipamorelin)
Frequency
Daily, often at night
Commonly associated areas
Illustrative map of the body systems CJC-1295 NO DAC+IPA is most often discussed in relation to. Relative emphasis only — not a measure of efficacy or a medical claim.
Proposed mechanisms / pathways
What is CJC-1295 NO DAC+IPA?
CJC-1295 NO DAC+IPA is a combination blend of two growth-hormone peptides: CJC-1295 (no-DAC), a short-acting GHRH analog also known as Mod GRF (1-29), and Ipamorelin, a selective growth-hormone secretagogue. Rather than introducing growth hormone directly, the pair is discussed in the context of prompting the pituitary gland to release more of the body’s own GH. The "no-DAC" label means the CJC-1295 component lacks the long-acting Drug Affinity Complex, so it clears quickly.
How it is thought to work
The two components are thought to act through different but complementary pathways. CJC-1295 binds the GHRH receptor, which is associated with raising the amplitude of natural GH pulses, while Ipamorelin acts on the ghrelin receptor (GHS-R1a) to help trigger a pulse. The common framing is that one raises the "volume" of the pulse while the other helps switch it on — which is why GHRH analogs and secretagogues are so often paired.
Educational only — not medical advice
CJC-1295 and Ipamorelin are research peptides and are not approved medications for general human use. Nothing here is a recommendation, dose, or medical claim. Consult a qualified healthcare provider and follow the laws in your area.
Tracking CJC-1295 NO DAC+IPA in LynkDose
Because this is a two-compound blend, the most useful habit is logging the combined dose and the time of day consistently — many take it at night. The effects people look for — sleep, recovery, and body composition — build slowly, so let objective metrics from Apple Health accumulate. In LynkDose the value comes from the multi-week trend, which is exactly what a tracker is built to surface.
Commonly discussed for
- Supporting the body’s natural growth-hormone pulse
- Recovery and sleep quality over longer timeframes
- Body-composition goals across a multi-week protocol
Often stacked: This is itself a stack — combining a GHRH analog (CJC-1295 no-DAC) with a GH secretagogue (Ipamorelin) so the two complementary pathways are used together.
How to track CJC-1295 NO DAC+IPA in LynkDose
Because this is a two-compound blend, log the combined dose and the time of day — many take it at night. Then watch sleep, recovery, and body-composition metrics trend over weeks rather than days.
Deeper read: How to Build and Track a Peptide Stack
Not medical advice
This page is educational and does not recommend, prescribe, or dose any compound. Many peptides are research chemicals not approved for general human use. Always consult a qualified healthcare provider and follow the laws in your area.